Splicing factor hnRNP A2 activates the Ras-MAPK-ERK pathway by controlling A-Raf splicing in hepatocellular carcinoma development

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

FIGURE 6.
FIGURE 6.

Sensitivity of HCC cells to MEK inhibitor–induced apoptosis correlates with hnRNP A1 and A2 levels. (A) Cells were lysed, and protein levels of hnRNP A2/B1, hnRNP A1/A1b, A-Raf FL and total and phosphorylated MEK1/2 and ERK1/2 were examined using Western blot. β-Actin was used as loading control. (B) HCC cell lines were treated either with vehicle or MEK inhibitor U0126 (10 µM) for 24 h and subjected to trypan blue exclusion assay. (C) Cells described in A and B were analyzed by Western blot for cleaved caspase-3, a marker for apoptosis. β-Actin served as loading control. (D) HuH7 cells transduced with the indicated retroviruses were seeded (120 × 104 cells/well in a six-well plate in triplicates) and treated with either vehicle or MEK inhibitor U0126 (10 µM) for 48 h and subjected to trypan blue exclusion assay. (*) Increased apoptosis after U0126 treatment in hnRNP A2 knockdown compared with MLP. P = 0.053. (E) Cells described in D were counted (total cell number) by a BioRad cell counter. (*) Reduced cell number after U0126 treatment in hnRNP A2 knockdown compared with MLP. P = 0.033. Experiments described in D and E were repeated at least twice.

This Article

  1. RNA 20: 505-515